CULVER CITY, Calif., Feb. 16, 2017 /PRNewswire-USNewswire/ -- Serving as the international forum for cutting edge research designed to speed the discovery of more and better treatments for cancer and other diseases, the World Molecular Imaging Society (WMIS) will hold its 10th annual congress in Philadelphia, September 13-16, 2017. The theme of the World Molecular Imaging Congress (WMIC) 2017 is "IMAGinING the Future: From Molecules to Medicine," which challenges the industry to fuel new ideas and spur new solutions that marry technology and biology to focus on early disease detection.
"Imagining the future of health from molecules to medicine, is about creating a new revolution in health—a massive transition from late-stage to early-stage detection. The late-stage diagnostics and medicines of today are simply too late to have a substantial impact on survival. We, as imaging scientists, must strive for a future in which biological sensing and imaging are all around us; to forge a new path and take bold steps to push the limits of sensitivity and specificity in early-stage detection. These advances will also likely fuel a revolution in optimal patient management in later stage disease," said Sanjiv (Sam) Gambhir, MD, Ph.D., President, WMIS 2017 and Chair, Department of Radiology at the Stanford University School of Medicine.
The WMIC 2017 will feature more than 200 oral presentations and more than 850 scientific poster presentations from world-renowned institutions from around the globe, with keynote sessions on advances that will refine animal models, accelerate research and improve clinical care. The WMIC Scientific Program Committee is currently accepting abstract submissions in the following emphases: Neuroscience; Oncology; Cardiology; Inflammation and Infectious Diseases; Metabolic Diseases; Instrumentation and Computation; Basic Biology and Bioengineering. The deadline to submit abstracts is Wednesday, March 15, 2017. For more information about WMIC 2017, visit http://www.wmis.org/meetings/.
"We want to emphasize that we believe that there are no borders where science and medicine are concerned. We encourage all researchers, imaging scientists, and clinicians to proudly submit your scientific abstracts for inclusion in the WMIC in Philadelphia in September. We are committed to the presentation of breakthrough research at the Conference, irrespective of geography, and will support our global membership in the coming months irrespective of any potential travel restrictions," said Dr. Gambhir.
ABOUT WORLD MOLECULAR IMAGING SOCIETY The WMIS is dedicated to developing and promoting translational research through multimodality molecular imaging. The education and abstract-driven WMIC is the annual meeting of the WMIS and is held in conjunction with partner societies including the European Society for Molecular Imaging (ESMI) and the Federation of Asian Societies for Molecular Imaging (FASMI). WMIC provides a unique setting for scientists and clinicians with very diverse backgrounds to interact, present, and follow cutting-edge advances in the rapidly expanding field of molecular imaging that impacts nearly every biomedical discipline. Industry exhibits at the congress included corporations who have created the latest advances in preclinical and clinical imaging approaches and equipment, providing a complete molecular imaging educational technology showcase. For more information: www.wmis.org
CONTACT: LISA BAIRD PHONE: 617-378-7682 E-MAIL: [email protected]
Advertisement
"Imagining the future of health from molecules to medicine, is about creating a new revolution in health—a massive transition from late-stage to early-stage detection. The late-stage diagnostics and medicines of today are simply too late to have a substantial impact on survival. We, as imaging scientists, must strive for a future in which biological sensing and imaging are all around us; to forge a new path and take bold steps to push the limits of sensitivity and specificity in early-stage detection. These advances will also likely fuel a revolution in optimal patient management in later stage disease," said Sanjiv (Sam) Gambhir, MD, Ph.D., President, WMIS 2017 and Chair, Department of Radiology at the Stanford University School of Medicine.
Advertisement
The WMIC 2017 will feature more than 200 oral presentations and more than 850 scientific poster presentations from world-renowned institutions from around the globe, with keynote sessions on advances that will refine animal models, accelerate research and improve clinical care. The WMIC Scientific Program Committee is currently accepting abstract submissions in the following emphases: Neuroscience; Oncology; Cardiology; Inflammation and Infectious Diseases; Metabolic Diseases; Instrumentation and Computation; Basic Biology and Bioengineering. The deadline to submit abstracts is Wednesday, March 15, 2017. For more information about WMIC 2017, visit http://www.wmis.org/meetings/.
"We want to emphasize that we believe that there are no borders where science and medicine are concerned. We encourage all researchers, imaging scientists, and clinicians to proudly submit your scientific abstracts for inclusion in the WMIC in Philadelphia in September. We are committed to the presentation of breakthrough research at the Conference, irrespective of geography, and will support our global membership in the coming months irrespective of any potential travel restrictions," said Dr. Gambhir.
ABOUT WORLD MOLECULAR IMAGING SOCIETY The WMIS is dedicated to developing and promoting translational research through multimodality molecular imaging. The education and abstract-driven WMIC is the annual meeting of the WMIS and is held in conjunction with partner societies including the European Society for Molecular Imaging (ESMI) and the Federation of Asian Societies for Molecular Imaging (FASMI). WMIC provides a unique setting for scientists and clinicians with very diverse backgrounds to interact, present, and follow cutting-edge advances in the rapidly expanding field of molecular imaging that impacts nearly every biomedical discipline. Industry exhibits at the congress included corporations who have created the latest advances in preclinical and clinical imaging approaches and equipment, providing a complete molecular imaging educational technology showcase. For more information: www.wmis.org
CONTACT: LISA BAIRD PHONE: 617-378-7682 E-MAIL: [email protected]
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/wmic-2017-imagining-the-future-call-for-abstracts-300409111.html
SOURCE World Molecular Imaging Society
